|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 403/12 | (2006.01) |
| A61K 31/497 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2379532 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09768586.1 |
| Date of filing the European patent application | 2009-12-10 | |
| (97) | Date of publication of the European application | 2011-10-26 |
| (45) | Date of publication and mention of the grant of the patent | 2013-02-20 |
| (46) | Date of publication of the claims translation | 2013-04-25 |
| (86) | Number | PCT/US2009/067437 |
| Date | 2009-12-10 |
| (87) | Number | WO 2010/077758 |
| Date | 2010-07-08 |
| (30) | Number | Date | Country code |
| 138176 P | 2008-12-17 | US |
| (72) |
FAROUZ, Francine, S., US
HOLCOMB, Ryan, Coatsworth, US
KASAR, Ramesh, US
MYERS, Steven, Scott, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Junginiai, naudingi CHK1 slopinimui |
| COMPOUNDS USEFUL FOR INHIBITING CHK1 |
| Payment date | Validity (years) | Amount | |
| 2025-11-18 | 17 | 347.00 EUR |
| 2026-12-10 |